pyrroles has been researched along with Atrial Fibrillation in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.13) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (31.91) | 29.6817 |
2010's | 31 (65.96) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calkins, H; Piccini, JP | 1 |
Brodowski, K; Jaworski, K; Kosior, DA; Krzykwa, A; Opolski, G; Zylińska, E | 1 |
Abaci, O; Coskun, U; Kilickesmez, KO; Kocas, C; Oktay, V; Yigit, Z; Yildiz, A; Yildiz, CE | 1 |
Lappegård, KT; Pop, G; Pop-Purceleanu, M; Sexton, J; Tendolkar, I; van Heerde, W | 1 |
Guo, F; Han, W; Li, JX; Li, YD; Tang, BP; Tang, Q; Zhang, YY | 1 |
Liu, X; Qu, Y; Shen, H; Xia, J | 1 |
Li, Y; Qi, X; Yang, Q | 1 |
Guan, Y; Guo, HY; Shan, ZL; Wang, YT; Yuan, HT; Zhang, Y | 1 |
Gu, HY; Jiang, L; Shi, MY; Teng, SC; Xue, FH; Yin, F; Zhu, J | 1 |
Crijns, HJ; De Boer, HC; De Jong, AM; Kamphuisen, PW; Kuiper, M; Lau, DH; Linz, D; Lumeij, S; Maass, AH; Rienstra, M; Schotten, U; Spronk, HM; Ten Cate, H; Van Gelder, IC; van Hunnik, A; van Zonneveld, AJ; Verheule, S; Zeemering, S | 1 |
Chiang, FT; Hwang, JJ; Lai, LP; Lin, JL; Tsai, CT; Wang, YC | 1 |
Kim, JH; Kim, JS; Kim, WS; Lee, SH; Lee, YT; On, YK; Shin, DH; Song, YB; Sung, J | 1 |
Almroth, H; Boman, K; Englund, A; Höglund, N; Jensen, S; Kjellman, B; Rosenqvist, M; Tornvall, P | 1 |
Kanic, V; Naji, F; Sabovic, M; Suran, D; Vokac, D | 1 |
Cai, J; Chi, L; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X; Xie, S | 1 |
Cai, JZ; Feng, J; Ji, Q; Mei, YQ; Sun, YF; Wang, XS; Xie, SL; Zhou, YX | 1 |
Aronow, WS; Banach, M; Bielecka-Dabrowa, A; Desai, R; Goch, JH; Maciejewski, M; Rysz, J | 1 |
Arai, H; Ito, F; Miyagi, N; Someya, T; Tamura, K; Ushiyama, T | 1 |
Abuladze, GV; Dundua, GI; Dzhindzholiia, NR; Nebieridze, MI | 1 |
Camm, J; Hosseini, MT; Jahangiri, M; Kourliouros, A; Mayr, M; Sarsam, M; Valencia, O | 1 |
Bentz, K; Eick, C; Kettering, K; Laszlo, R; Menzel, KA; Schreieck, J; Schreiner, B | 1 |
Takagi, H; Umemoto, T | 1 |
Bloom, HL; Dudley, SC; Jones, DP; Negi, S; Shukrullah, I; Veledar, E | 1 |
Kuo, CD | 1 |
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, S; Rosenqvist, M; Tornvall, P | 1 |
Bouwels, L; de Leeuw, FE; Enajat, M; Pop, G; Pop-Purceleanu, M; Tendolkar, I; van Kuilenburg, J; van Wingen, G; Zwiers, MP | 1 |
Cai, J; Chi, L; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X | 1 |
Chaitman, BR; Goldberger, JJ; Messig, M; Schwartz, GG | 1 |
Akilli, H; Alihanoglu, Y; Altunkeser, BB; Aribas, A; Ayhan, S; Can, I; Demir, K; Koc, F; Vatankulu, MA | 1 |
Asirvatham, SJ; Bradley, D; Brady, PA; Cha, YM; Friedman, PA; Herges, R; Hodge, D; Koestler, C; Lerman, A; Lopez-Jimenez, F; Munger, TM; Packer, DL; Suleiman, M | 1 |
Goette, A | 1 |
Komatsu, T; Kunugita, F; Nakamura, M; Ozawa, M; Sato, Y; Tachibana, H | 1 |
Bidhendi, LM; Bina, P; Fathollahi, MS; Karimi, A; Molai, M; Rezvanfard, M; Sadeghian, S; Yousefi, A; Zare, E | 1 |
Fenech, ME; Mackay, JW; Myint, KS | 1 |
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, SM; Rosenqvist, M; Tornvall, P | 1 |
Creswell, LL | 1 |
Bang, CN; Gislason, GH; Greve, AM; Køber, L; Torp-Pedersen, C; Wachtell, K | 1 |
Dernellis, J; Panaretou, M | 1 |
Altinbas, A; Aslan, SM; Dogan, A; Kucuktepe, Z; Ozaydin, M; Ozturk, M; Varol, E | 1 |
Candura, D; Chello, M; Covino, E; D'Ambrosio, A; Di Sciascio, G; Pasceri, V; Patti, G | 1 |
García-Fernández, A; Mainar, L; Marín, F; Martínez, JG; Roldán, V | 1 |
Hawkins, NM; MacDonald, MR; Padfield, GJ | 1 |
Orlandi, QG; Shroff, GR | 1 |
Brozmanova, K; Mardiak, J; Mego, M; Obertova, J; Reckova, M; Sycova-Mila, Z | 1 |
Blazing, M; Cannon, CP; Gersh, B; McLean, DS; Ravid, S; Shui, A | 1 |
Camm, J; De Souza, A; Jahangiri, M; Kourliouros, A; Marciniak, A; Roberts, N; Tsiouris, A; Valencia, O | 1 |
Johnson, RW; Keenan, TH; Kosh, JW; Sowell, JW | 1 |
2 review(s) available for pyrroles and Atrial Fibrillation
Article | Year |
---|---|
The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials.
Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Odds Ratio; Primary Prevention; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Secondary Prevention; Treatment Outcome | 2014 |
Effect of Atorvastatin on Serum Levels of Total Cholesterol and High-Sensitivity C-reactive Protein in High-Risk Patients with Atrial Fibrillation in Asia.
Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Treatment Outcome | 2015 |
20 trial(s) available for pyrroles and Atrial Fibrillation
Article | Year |
---|---|
Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload.
Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Cardiac; Disease-Free Survival; Double-Blind Method; Emergency Treatment; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Myocardial Infarction; Postoperative Complications; Preoperative Care; Prospective Studies; Pyrroles; Treatment Outcome | 2014 |
Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
Topics: Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Combined Modality Therapy; Confidence Intervals; Echocardiography, Doppler; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pacemaker, Artificial; Probability; Proportional Hazards Models; Prospective Studies; Pyrroles; Reference Values; Risk Assessment; Survival Analysis; Treatment Outcome | 2008 |
The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery.
Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Postoperative Complications; Premedication; Prospective Studies; Pyrroles | 2008 |
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study.
Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Double-Blind Method; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Secondary Prevention; Sweden; Treatment Outcome | 2009 |
Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting.
Topics: Administration, Oral; Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Preoperative Care; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2009 |
[Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting].
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrroles; Risk Factors | 2009 |
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.
Topics: Adult; Aged; Atorvastatin; Atrial Fibrillation; Body Mass Index; Cardiomyopathy, Dilated; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles; Tumor Necrosis Factor-alpha | 2010 |
Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial.
Topics: Aged; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass; Drug Administration Schedule; Female; Heart Valve Prosthesis Implantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; London; Male; Middle Aged; Preoperative Care; Prospective Studies; Pyrroles; Regression Analysis; Risk Assessment; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome | 2011 |
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).
Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Inflammation Mediators; Male; Middle Aged; Oxidative Stress; Pyrroles; Treatment Outcome | 2011 |
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Electric Countershock; Female; Fibrinolysis; Heptanoic Acids; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles; Recurrence; Tissue Plasminogen Activator | 2011 |
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Atrophy; Azetidines; Biomarkers; Cholesterol; Double-Blind Method; Ezetimibe; Female; Heptanoic Acids; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Pyrroles; Temporal Lobe | 2012 |
Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting.
Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Postoperative Period; Preoperative Period; Pyrroles; Treatment Outcome | 2011 |
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Topics: Atorvastatin; Atrial Fibrillation; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Retrospective Studies; Stroke; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
Topics: Analysis of Variance; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Electric Countershock; Female; Fibrinogen; Health Status Indicators; Heptanoic Acids; Humans; Leukocyte Count; Male; Middle Aged; Pyrroles; Secondary Prevention; Time Factors; Warfarin | 2011 |
Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Pyrroles; Quality of Life; Secondary Prevention; Treatment Outcome | 2012 |
The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.
Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles; Recurrence; Treatment Outcome | 2013 |
Effect of C-reactive protein reduction on paroxysmal atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles | 2005 |
Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Body Mass Index; C-Reactive Protein; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrroles; Recurrence; Risk Factors; Treatment Outcome | 2006 |
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cardiac Surgical Procedures; Cerebrovascular Disorders; Female; Heart Diseases; Heptanoic Acids; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Pyrroles | 2006 |
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atorvastatin; Atrial Fibrillation; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Pyrroles; Thrombolytic Therapy; Tirofiban; Tyrosine | 2008 |
25 other study(ies) available for pyrroles and Atrial Fibrillation
Article | Year |
---|---|
Catheter ablation of rotational activity in atrial fibrillation: A barren oasis?
Topics: Atrial Fibrillation; Catheter Ablation; Follow-Up Studies; Heart Atria; Humans; Pyrroles; Vinyl Compounds | 2018 |
[Role of inflammation in etiology of atrial fibrillation--is lone arrhythmia really alone].
Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrroles; Recurrence | 2012 |
Comparison of rosuvastatin versus atorvastatin for preventing postoperative atrial fibrillation.
Topics: Atorvastatin; Atrial Fibrillation; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Premedication; Prevalence; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Turkey | 2013 |
Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.
Topics: Aged; Amygdala; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Azetidines; Brain; Cognition; Electrocardiography; Executive Function; Ezetimibe; Female; Heptanoic Acids; Hippocampus; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Memory; Neuroimaging; Neuropsychological Tests; Psychomotor Performance; Pyrroles; Reaction Time; Vocabulary | 2013 |
Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation.
Topics: Adult; Atorvastatin; Atrial Fibrillation; Atrial Function, Left; Echocardiography; Female; Heart Atria; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Pyrroles | 2013 |
Role of inflammation in the initiation and maintenance of atrial fibrillation and the protective effect of atorvastatin in a goat model of aseptic pericarditis.
Topics: Animals; Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Cytokines; Disease Models, Animal; Goats; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Pericarditis; Pyrroles | 2015 |
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
Topics: Analysis of Variance; Animals; Antithrombins; Atrial Fibrillation; Cell Proliferation; Dabigatran; Female; Fibrinolytic Agents; Fibroblasts; Fibrosis; Goats; Heart Atria; Indazoles; Mice, Transgenic; Nadroparin; Peptide Hydrolases; Pyrroles; Quinazolines; Rats; Receptors, Thrombin; Thrombin; Thrombophilia; Urea | 2017 |
Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion.
Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Odds Ratio; Pyrroles; Retrospective Studies; Simvastatin; Treatment Outcome | 2009 |
Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Disease-Free Survival; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pravastatin; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
[The efficasy of atorvastatin in the case of paroxismal atrial fibrillation in patients with ischemic heart disease].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Treatment Outcome | 2010 |
Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits.
Topics: Animals; Atorvastatin; Atrial Fibrillation; Female; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Ion Channels; Oxidative Stress; Patch-Clamp Techniques; Pyrroles; Rabbits; Tachycardia; Time Factors | 2010 |
Effect of preoperative statin therapy on postoperative atrial fibrillation in cardiac surgery.
Topics: Administration, Oral; Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Preoperative Care; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Statins, inflammation, oxidative stress, and atrial fibrillation.
Topics: Atorvastatin; Atrial Fibrillation; Female; Heptanoic Acids; Humans; Male; Pyrroles | 2011 |
Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation?
Topics: Atorvastatin; Atrial Fibrillation; Catheter Ablation; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Postoperative Complications; Pulmonary Veins; Pyrroles | 2012 |
Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin.
Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Pyrroles; Retrospective Studies; Secondary Prevention; Tachycardia, Paroxysmal; Time Factors; Treatment Outcome | 2011 |
The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Postoperative Complications; Pyrroles; Retrospective Studies | 2012 |
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.
Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin | 2012 |
Invited commentary.
Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Postoperative Complications; Pyrroles | 2012 |
Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Comorbidity; Denmark; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Polypharmacy; Pravastatin; Propensity Score; Proportional Hazards Models; Pyrroles; Registries; Retrospective Studies; Risk Factors; Sex Factors; Simvastatin; Time Factors; Treatment Outcome | 2014 |
Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion.
Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Secondary Prevention | 2006 |
Letter by Padfield et al regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Ca
Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Research Design | 2007 |
Letter by Shroff and Orlandi regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia Afte
Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Coronary Artery Bypass; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Research Design | 2007 |
Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.
Topics: Aged; Atrial Fibrillation; Benzenesulfonates; Carcinoma, Renal Cell; Cardiovascular Diseases; Chest Pain; Drug Interactions; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Middle Aged; Myocardial Ischemia; Neoplasm Invasiveness; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Risk Assessment; Sampling Studies; Severity of Illness Index; Sorafenib; Sunitinib | 2007 |
Dose-related effect of statins on atrial fibrillation after cardiac surgery.
Topics: Aged; Aged, 80 and over; Aortic Valve; Atorvastatin; Atrial Fibrillation; Cohort Studies; Coronary Artery Bypass; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Heart Valve Prosthesis Implantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Postoperative Complications; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Treatment Outcome | 2008 |
Synthesis of substituted 2-aminopyrrole analogs of lidocaine II.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical Phenomena; Chemistry; Guinea Pigs; Lidocaine; Male; Mice; Pyrroles; Structure-Activity Relationship | 1979 |